- Citations, last 5 years
- 122
- Works, last 5 years
- 3
- h-index
- 7
- Scientists listed
- 0
- Grants since 2016
- 9
Grants received
2025–2026 · research · R43
Bio-Click: A cell-free high-throughput platform for the engineering of enzymatic group transfer reactions
John Martin Billingsley · Invizyne Technologies (United States) · funded by National Institutes of Health
2024–2025 · research · R43
GlyCoSAM: Glycolysis coupled S-adenosyl methionine regeneration for cell-free methylation reactions
Adrian Brueckner · Invizyne Technologies (United States) · funded by National Institutes of Health
2021–2024 · research · R44
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis
Tyler P Korman · Invizyne Technologies (United States) · funded by National Institutes of Health
2021–2024 · research · R44
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis
Tyler P Korman · Invizyne Technologies (United States) · funded by National Institutes of Health
2021–2024 · research · R44
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis
Tyler P Korman · Invizyne Technologies (United States) · funded by National Institutes of Health
2021–2024 · research · R44
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis
Tyler P Korman · Invizyne Technologies (United States) · funded by National Institutes of Health
2021–2024 · research · R44
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis
Tyler P Korman · Invizyne Technologies (United States) · funded by National Institutes of Health
2021–2024 · research · R44
SimplePath II: A Cell-free Enzymatic Platform for Cannabinoid Biosynthesis
Tyler P Korman · Invizyne Technologies (United States) · funded by National Institutes of Health
2020–2021 · research · R43
SimplePath: A Cell-free Enzymatic Platform for Cannabinoid Boisynthesis
Tyler P Korman · Invizyne Technologies (United States) · funded by National Institutes of Health
